Clinical Trials Biogen’s Spinraza set to increase its chances to maintain a strong position in spinal muscular atrophy 12 Jan 2021
Impel doses first subject in Phase l trial of INP105 Impel NeuroPharma has dosed the first subject in the Phase l Safety and Tolerability of... 30th August 2018
Clinical Research Reify Health extends StudyTeam platform availability for clinical trials 21 Jan 2021